Why does the site say “<155 nm” instead of an exact lower bound?

GC-UV detection extends well into the vacuum-UV, but the exact lower wavelength a given system reaches depends on the flow cell design, window material, carrier-gas purity, optical path length, and the absorbing species in the sample. Quoting a single fixed number would imply a guaranteed limit across all configurations and matrices, which isn't physically accurate. “<155 nm” communicates the meaningful capability — operation in the vacuum-UV — without overstating performance you can't reproduce in your own setup.

What actually limits the lower wavelength?

Three things dominate: (1) absorption by the carrier gas itself (N₂ is largely transparent down to ~145 nm; O₂ and H₂O cut in much earlier), (2) the transmission cutoff of the flow-cell windows (MgF₂, LiF, and synthetic silica each have different deep-UV cutoffs), and (3) lamp emission and detector quantum efficiency at very short wavelengths. INSCAN is engineered so all three are pushed as far into the vacuum-UV as the application requires.

Does GC-UV always operate at the lowest possible wavelength?

No — and it shouldn't. The optimal wavelength window is chosen per analyte. Many compound classes have their strongest, most selective absorption bands above 155 nm. Going lower buys you sensitivity for non-UV-active compounds and class-level fingerprints, but it isn't free: shorter wavelengths require stricter purge, cleaner gas, and shorter optical paths.

How should I interpret the spec sheets?

Treat the published range (typ. <155–330 nm) as the envelope INSCAN can operate within. The wavelength range that's relevant to your method is a subset chosen during method development, based on your analytes, matrix, and required limits of detection. Our applications team confirms the working window during a feasibility scan.

Is “<155 nm” a marketing hedge?

It's the opposite — it's the honest framing. A specific sub-155 nm number would only be defensible under one configuration with one sample. The “<155 nm” phrasing matches how peer-reviewed GC-UV literature describes vacuum-UV operation, and it's consistent with how spectroscopy vendors quote ranges (e.g. “below 200 nm” for deep-UV HPLC detectors).

What does “far below 155 nm” actually mean in practice?

“Far below 155 nm” means the optical path is engineered to keep transmitting useful signal deep into the vacuum-UV — typically into the 130–150 nm region, and in some configurations approaching the LiF cutoff near 105 nm. In that regime almost every organic molecule has a strong σ→σ* or n→σ* absorption, so even compounds that look “UV-transparent” in conventional HPLC detectors (alkanes, fixed gases, simple halocarbons) become detectable with class-specific spectra.

What limits performance at the deepest wavelengths?

Four things, in order of impact: (1) residual O₂ and H₂O in the carrier and purge gas — both absorb strongly below ~180 nm; (2) window contamination — even a monolayer of pump oil, plasticiser, or fingerprint residue raises the cutoff dramatically; (3) lamp ageing — D₂ and Xe lamps lose deep-UV output before they lose visible output; (4) sample loading — overloaded peaks saturate the detector and broaden into the baseline.

How should customers prepare samples for deep-UV GC-UV work?

Treat it like trace GC-MS, with two extra rules. First, eliminate water and oxygen from the sample path: dry solvents, low-bleed septa, and a fresh split liner before any deep-UV run. Second, control matrix loading — dilute heavy matrices so total mass on-column stays below ~100 ng per analyte. Use UV-grade carrier gas (≥99.9999% N₂ or He) with an in-line O₂/H₂O trap.

How does GC-UV improve genotoxic impurity (NDMA / NDEA) testing in pharma?

GC-UV records the full electronic absorption spectrum of every eluting compound, giving an identity that is orthogonal to mass spectrometry. For nitrosamines such as NDMA and NDEA, this provides a second, structure-based confirmation that defends against false positives from isobaric interferences common in API matrices.

Can INSCAN replace GC-MS for ICH Q3C residual solvent analysis?

INSCAN can serve as the primary detector or as an orthogonal confirmation alongside MS. For most ICH Q3C class 1 and 2 solvents — including positional isomers like xylenes and dichloroethanes — UV spectra deliver baseline-resolved identification with Lambert-Beer-traceable quantitation across more than four decades.

Is GC-UV accepted under USP and EP 2.4.24?

USP and EP 2.4.24 are detector-agnostic: they specify performance criteria (linearity, LOQ, specificity) rather than mandating a detector. GC-UV satisfies all of these criteria and is increasingly used as either the primary or confirmatory detector in compendial workflows.

Does INSCAN integrate with existing GC-FID or GC-MS instruments in QC labs?

Yes. INSCAN LAB is engineered as a drop-in detector that attaches in line with or in place of an FID, leaving the existing GC method, autosampler and data system untouched. Most pharma QC labs validate the addition with a comparative bridging study.

What detection limits can GC-UV reach for pharma impurities?

Compound-dependent detection limits are typically in the low- to sub-ppb range for aromatic and conjugated impurities, with linear quantitation extending across more than four orders of magnitude — sufficient for ICH Q3A/B threshold work and most genotoxic impurity panels.

All impact areas

Pharma QC

Pharmaceutical Quality Control

Q: Why does the site say “<155 nm” instead of an exact lower bound?

GC-UV detection extends well into the vacuum-UV, but the exact lower wavelength a given system reaches depends on the flow cell design, window material, carrier-gas purity, optical path length, and the absorbing species in the sample. Quoting a single fixed number would imply a guaranteed limit across all configurations and matrices, which isn't physically accurate. “<155 nm” communicates the meaningful capability — operation in the vacuum-UV — without overstating performance you can't reproduce in your own setup.

Q: What actually limits the lower wavelength?

Three things dominate: (1) absorption by the carrier gas itself (N₂ is largely transparent down to ~145 nm; O₂ and H₂O cut in much earlier), (2) the transmission cutoff of the flow-cell windows (MgF₂, LiF, and synthetic silica each have different deep-UV cutoffs), and (3) lamp emission and detector quantum efficiency at very short wavelengths. INSCAN is engineered so all three are pushed as far into the vacuum-UV as the application requires.

Q: Does GC-UV always operate at the lowest possible wavelength?

No — and it shouldn't. The optimal wavelength window is chosen per analyte. Many compound classes have their strongest, most selective absorption bands above 155 nm. Going lower buys you sensitivity for non-UV-active compounds and class-level fingerprints, but it isn't free: shorter wavelengths require stricter purge, cleaner gas, and shorter optical paths.

Q: How should I interpret the spec sheets?

Treat the published range (typ. <155–330 nm) as the envelope INSCAN can operate within. The wavelength range that's relevant to your method is a subset chosen during method development, based on your analytes, matrix, and required limits of detection. Our applications team confirms the working window during a feasibility scan.

Q: Is “<155 nm” a marketing hedge?

It's the opposite — it's the honest framing. A specific sub-155 nm number would only be defensible under one configuration with one sample. The “<155 nm” phrasing matches how peer-reviewed GC-UV literature describes vacuum-UV operation, and it's consistent with how spectroscopy vendors quote ranges (e.g. “below 200 nm” for deep-UV HPLC detectors).

Q: What does “far below 155 nm” actually mean in practice?

“Far below 155 nm” means the optical path is engineered to keep transmitting useful signal deep into the vacuum-UV — typically into the 130–150 nm region, and in some configurations approaching the LiF cutoff near 105 nm. In that regime almost every organic molecule has a strong σ→σ* or n→σ* absorption, so even compounds that look “UV-transparent” in conventional HPLC detectors (alkanes, fixed gases, simple halocarbons) become detectable with class-specific spectra.

Q: What limits performance at the deepest wavelengths?

Four things, in order of impact: (1) residual O₂ and H₂O in the carrier and purge gas — both absorb strongly below ~180 nm; (2) window contamination — even a monolayer of pump oil, plasticiser, or fingerprint residue raises the cutoff dramatically; (3) lamp ageing — D₂ and Xe lamps lose deep-UV output before they lose visible output; (4) sample loading — overloaded peaks saturate the detector and broaden into the baseline.

Q: How should customers prepare samples for deep-UV GC-UV work?

Treat it like trace GC-MS, with two extra rules. First, eliminate water and oxygen from the sample path: dry solvents, low-bleed septa, and a fresh split liner before any deep-UV run. Second, control matrix loading — dilute heavy matrices so total mass on-column stays below ~100 ng per analyte. Use UV-grade carrier gas (≥99.9999% N₂ or He) with an in-line O₂/H₂O trap.

Confirm structure, not just mass — for APIs, excipients, and release testing.

The Context

Pharmaceutical QC laboratories live and die by the certainty of their identifications. Regulatory frameworks — ICH Q3A/B, USP <467>, EP 2.4.24 — demand confirmation of impurities and residual solvents at increasingly low levels. The hardest cases are positional and stereo-isomers of an active ingredient: they share a molecular formula and a mass spectrum, yet differ in toxicology, potency, and stability. GC-UV resolves these structural ambiguities directly from the electronic spectrum, providing a second, orthogonal dimension of identity that mass spectrometry cannot deliver alone.

The Challenges

What conventional detection misses.

Genotoxic impurities at ppm levels

Nitrosamines, alkyl halides and aromatic amines must be quantified far below the API's specification — and unambiguously distinguished from benign isomers.

Residual solvent class confirmation

ICH Q3C class 1 and 2 solvents include positional isomers (e.g. xylenes, dichloroethanes) that elute close to one another on standard columns.

Cross-contamination in shared facilities

Multi-product lines need rapid, unambiguous detection of trace carryover between API campaigns.

The GC-UV Answer

How INSCAN resolves it.

Electronic absorption spectra in 176–330 nm provide a structural fingerprint independent of fragmentation behaviour.
Lambert-Beer quantification removes ionisation variability — calibration curves are linear over four orders of magnitude.
Non-destructive detection allows a downstream MS or FID confirmation on the same chromatographic run.

At a glance

Linear range: >4 decades
Spectral range: 176–330 nm
Detection limit: ppb (compound dependent)

The Workflow

What the lab actually does.

STEP 01
Sample prep
Standard headspace or liquid injection — no derivatisation required for most impurity panels.
STEP 02
Separation
Existing GC method retained; INSCAN attaches in line with or in place of the FID.
STEP 03
Spectral acquisition
Full UV spectrum captured at every chromatographic point — no scan-time penalty.
STEP 04
Library match
Automatic comparison against in-house and reference UV libraries; reviewer confirms with a single click.

Where it's used

Typical applications.

Genotoxic impurity screening (NDMA, NDEA, NMBA)
Residual solvent analysis per ICH Q3C / USP <467>
API isomer purity (ortho/meta/para; cis/trans)
Cleaning validation in shared manufacturing suites
Excipient identity and supplier qualification

Recommended platforms

The right INSCAN for Pharma QC.

Recommended

INSCAN LAB

Drop-in benchtop detector for routine QC labs already running GC-FID or GC-MS.

Explore product

Recommended

INSCAN

Integrated GC-UV platform for high-throughput release testing.

Explore product

Questions answered

GC-UV for Pharma QC — FAQ.

Specifics that matter to lab managers, method developers and process owners evaluating GC-UV against existing GC-MS or GC-FID workflows.

How does GC-UV improve genotoxic impurity (NDMA / NDEA) testing in pharma?: GC-UV records the full electronic absorption spectrum of every eluting compound, giving an identity that is orthogonal to mass spectrometry. For nitrosamines such as NDMA and NDEA, this provides a second, structure-based confirmation that defends against false positives from isobaric interferences common in API matrices.
Can INSCAN replace GC-MS for ICH Q3C residual solvent analysis?: INSCAN can serve as the primary detector or as an orthogonal confirmation alongside MS. For most ICH Q3C class 1 and 2 solvents — including positional isomers like xylenes and dichloroethanes — UV spectra deliver baseline-resolved identification with Lambert-Beer-traceable quantitation across more than four decades.
Is GC-UV accepted under USP <467> and EP 2.4.24?: USP <467> and EP 2.4.24 are detector-agnostic: they specify performance criteria (linearity, LOQ, specificity) rather than mandating a detector. GC-UV satisfies all of these criteria and is increasingly used as either the primary or confirmatory detector in compendial workflows.
Does INSCAN integrate with existing GC-FID or GC-MS instruments in QC labs?: Yes. INSCAN LAB is engineered as a drop-in detector that attaches in line with or in place of an FID, leaving the existing GC method, autosampler and data system untouched. Most pharma QC labs validate the addition with a comparative bridging study.
What detection limits can GC-UV reach for pharma impurities?: Compound-dependent detection limits are typically in the low- to sub-ppb range for aromatic and conjugated impurities, with linear quantitation extending across more than four orders of magnitude — sufficient for ICH Q3A/B threshold work and most genotoxic impurity panels.

Talk to us about Pharma QC.

Application notes, sample testing, and integration discussions for licensing, co-development, and OEM partners.

More areas of impact

Pharmaceutical Quality Control

What conventional detection misses.

Genotoxic impurities at ppm levels

Residual solvent class confirmation

Cross-contamination in shared facilities

How INSCAN resolves it.

What the lab actually does.

Sample prep

Separation

Spectral acquisition

Library match

Typical applications.

The right INSCAN for Pharma QC.

INSCAN LAB

INSCAN

GC-UV for Pharma QC — FAQ.

Talk to us about Pharma QC.

Explore other industries.

Petrochemical

Environmental

Forensic Toxicology

Polymer & Monomer